Company Active LTD

Company profile

Deephealth UK Limited

Kheiron - AI Platform & Solutions for Radiology - Detect Cancer Earlier

Discover how Kheiron's Artificial Intelligence solutions and AI platform for breast screening help radiologists detect cancer earlier. Join the AI revolution.

CRN
10184103
Founded
2016
Age
10

Overview

Legal name
DEEPHEALTH UK LIMITED
Region
Unknown
Registered address
1 BLOSSOM YARD
FOURTH FLOOR
LONDON
UNITED KINGDOM
E1 6RS
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Deephealth UK Limited
CRN 10184103
2
Direct and ultimate controller Active LTD
T B Builders Limited
CRN 04528434

Company events

Reference milestones and recent Companies House filing stream events.

18 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

30 May
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

16 May
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

22 Nov
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURGUDNRNTdhZGlxemtjeA | Paper/PDF filed

Published 23 Nov 2024 11:14

22 Nov
2024

Memorandum Articles

Incorporation

MA | Transaction MzQ0Mjc5MDMwNmFkaXF6a2N4 | Paper/PDF filed

Published 23 Nov 2024 11:07

23 Oct
2024

Notification Of A Person With Significant Control

Persons-with-significant-control

PSC02 | Transaction MzQ0MDQ3MTM5OGFkaXF6a2N4

Published 23 Oct 2024 09:49

22 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MDQ3MTM4N2FkaXF6a2N4

Published 22 Oct 2024 11:25

22 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MDQ3MTM5MmFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MDQ3MTM4OWFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Appoint Corporate Secretary Company With Name Date

Officers

AP04 | Transaction MzQ0MDQ3MTQwMWFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ0MDQ3MTM5OWFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Withdrawal Of A Person With Significant Control Statement

Persons-with-significant-control

PSC09 | Transaction MzQ0MDQ3MTM5NWFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MDQ3MTM4NWFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MDQ3MTM4NGFkaXF6a2N4

Published 22 Oct 2024 11:20

22 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MDQ3MTMzNWFkaXF6a2N4

Published 22 Oct 2024 11:19

03 Oct
2024

Accounts With Accounts Type Total Exemption Full

Accounts PDF pending

AA | Transaction MzQzNzYzODI2N2FkaXF6a2N4 | Paper/PDF filed

Published 05 Oct 2024 06:20

17 May
2016

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2017
Funded years
2017, 2018, 2019, 2020
Age at first award
0 years

Projects

2020 Feasibility Studies Lead participant

Breast Screening Exemplar: project delay and increased costs following the Covid-19 pandemic

1 Jun 2020 to 30 Nov 2020

Awarded
£185,423
Total cost £185,423

no public description

2020 Feasibility Studies Lead participant

Adaptation of Mia® (Mammography Intelligence Assessment) to support breast screening programmes to address Covid-19-related breast screening backlog

1 Jun 2020 to 28 Feb 2021

Awarded
£74,760
Total cost £74,760

Due to the Covid-19 outbreak, multiple routine NHS services are on pause, including breast screening programmes. An estimated 3-9 month delay in women being screened will lead to more cancers being missed at the stage where they are easier to treat and immense pressure on an already overburdened system. Our breast cancer screening AI solution Mia (Mammogr...

2019 Collaborative R&D

I-CAIRD: Industrial Centre for AI Research in Digital Diagnostics

1 Feb 2019 to 31 Mar 2023

Awarded
£348,268
Total cost £497,526

"iCAIRD will be a Scottish centre of excellence, centred at the Queen Elizabeth University Hospital in Glasgow but with sites across Scotland, to enable joined up academic and commercial technology development and research, locally and nationally. Making use of the capability of modern computers to process the large amounts of data gathered in healthcare ...

2019 Collaborative R&D

London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare

1 Feb 2019 to 31 Mar 2023

Awarded
£89,381
Total cost £127,687

"The London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will improve NHS patient care and health outcomes, reduce healthcare costs and support the growth of companies, supporting the economy. It will do this by applying artificial intelligence technologies to medical imaging (for example MRI scans, CT scans PET scans and ul...

2019 Collaborative R&D Lead participant

Mammo - Mammography breast cancer screening software for radiologists

1 Jan 2019 to 31 Dec 2020

Awarded
£422,512
Total cost £606,883

**Challenge** -- Breast Cancer (BC) is the UK's most common cancer (Cancer Research UK, 2018). The NHS screens 2.2m UK women annually and detects 18K BCs. Early

2018 Collaborative R&D

Capacity, Confidence, Care - Using Artificial Intelligence and Machine Learning to support Breast Screening

1 Oct 2018 to 31 Dec 2020

Awarded
£297,449
Total cost £424,927

"The diagnosis of cancer and other diseases often uses imaging tests (CT, MRI, x-ray, ultrasound) as part of the pathway of investigation. In the NHS, the number of imaging tests which need to be performed, outstrips the ability of the healthcare services to provide and/or interpret these tests. This can lead to delays in diagnosis and delays to subsequen...

2017 Feasibility Studies Lead participant

Kheiron Proof of Concept

1 Apr 2017 to 31 Mar 2018

Awarded
£197,868
Total cost £282,669

Kheiron have identified an opportunity to develop novel, widely applicable computer aided diagnosis (CAD) software tools that help radiologists with cancer discovery and tracking in clinical practice by leveraging the power of artificial intelligence and machine learning algorithms closely combined with high performance computing, healthcare IT insights a...

Product types

Collaborative R&D Feasibility Studies